Description

The Diabetes Management for the Nephrology Care Team was a full-day Early Program held immediately prior to the main ASN Kidney Week 2025 Annual Meeting. This course was designed to address the “technological revolution” in diabetes care—specifically the rapid adoption of Continuous Glucose Monitoring (CGM) and automated insulin delivery systems—and how these tools must be adapted for patients with Chronic Kidney Disease (CKD) and kidney failure.

Held in Houston, the program emphasized a “team-based” approach, acknowledging that optimal diabetes management in nephrology requires coordination between nephrologists, pharmacists, and diabetes educators to manage complex new drug classes like GLP-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists (nsMRAs).

What You Will Learn

The curriculum focused on the practical implementation of new standards of care. Key learning outcomes included:

CGM Mastery: How to interpret Ambulatory Glucose Profiles (AGP) and “Time in Range” specifically for patients on dialysis, where traditional A1c metrics are often unreliable.

New Therapeutics: “How and for Whom” to prescribe new glucose-lowering therapies (SGLT2 inhibitors, GLP-1 RAs, GIP/GLP-1 co-agonists) safely in advanced CKD and transplant recipients.

Insulin Automation: Understanding the mechanics of “Closed-Loop” insulin pumps (Automated Insulin Delivery) and how to troubleshoot them in a hospital or dialysis setting.

Biomarker Nuances: Beyond A1c—using glycated albumin and fructosamine to assess glycemic control in patients with anemia or high erythrocyte turnover.